Agenus reported $41M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US $ 41M 6.46M
Amgen AMGN:US $ 1256M 147M
Bristol Myers Squibb BMY:US $ 2882M 62M
Celldex Therapeutics CLDX:US $ 0.9M 0.12M
Chemocentryx CCXI:US $ 7.59M 2.17M
Dynavax Technologies DVAX:US $ 4.96M 15.24M
Eli Lilly And LLY:US $ 1659.3M 226M
Genocea Biosciences GNCA:US $ 0.59M 0.09M
Intrexon XON:US $ 2.67M 1.75M
Jiangsu Hengrui Me. 600276:CH CH 1.34B 371.43M
Karyopharm Therapeutics KPTI:US $ 1.69M 1.75M
Macrogenics MGNX:US $ 2.61M 1.12M
Merck MRK:GR € 2456M 100M
Novartis NOVN:VX 4.97B 114M
Novavax NVAX:US $ 386.49M 251.36M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Rigel Pharmaceuticals RIGL:US $ 2.15M 2.46M
Sangamo Biosciences SGMO:US 13.08M 1.93M
Veracyte VCYT:US $ 10.33M 0.94M
YTE INCY:US $ 194.77M 42.22M